VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Wednesday, December 31, 2025
Stock Comparison
Pfizer Inc. vs Unilever PLC
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Pfizer Inc.
PFE · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Unilever PLC
ULVR · London Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Unilever PLC's moat claims, evidence, and risks.
View ULVR analysisComparison highlights
- Moat score gap: Unilever PLC leads (65 / 100 vs 58 / 100 for Pfizer Inc.).
- Segment focus: Pfizer Inc. has 5 segments (47.4% in Primary Care); Unilever PLC has 4 segments (25.9% in Personal Care).
- Moat breadth: Pfizer Inc. has 8 moat types across 3 domains; Unilever PLC has 3 across 2.
Primary market context
Pfizer Inc.
Primary Care
Branded primary care medicines and vaccines (incl. cardiovascular, migraine, pneumococcal/RSV/COVID-19)
Global
Healthcare providers, payers/PBMs, pharmacies/wholesalers, and government procurement
Innovator biopharma (R&D + manufacturing + commercialization)
47.4%
Unilever PLC
Personal Care
Branded personal care and hygiene (deodorants, skin cleansing, oral care)
Global
Consumers (retail, e-commerce)
Brand owner / manufacturer
25.9%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
Pfizer Inc. strengths
Unilever PLC strengths
Segment mix
Pfizer Inc. segments
Full profile >Primary Care
Oligopoly
Specialty Care
Oligopoly
Oncology
Competitive
Pfizer CentreOne
Competitive
Pfizer Ignite
Competitive
Unilever PLC segments
Full profile >Beauty & Wellbeing
Oligopoly
Personal Care
Oligopoly
Home Care
Oligopoly
Foods
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.